1Edwards BS, Zimmermann RS, Burnett JC Jr. Atrial natriuretic factor: physiologic action and implications in congestive heart failure.Cardiovasc Drugs Ther,1987, 1 : 89-100. 被引量：1
2Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (pro-BNP) circulates in human plasma. Biochem Biophysl Res Commun, 1995, 214:1175-1183. 被引量：1
3Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive aminoterminal pro-brain natriuretie peptide (NT-PROBNP) : a new marker of cardiac impairment. Clin Endocrinol, 1997, 47 : 287-296. 被引量：1
4Sahn D J, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation of M-mode echecardiography: results of survey of echecardiography measurements. Circulation, 1978, 58 : 1072-1083. 被引量：1
5Vogeser M, Jacob K. B-type natriuretic peptide (BNP)--validation of an immediate response assay. Clin Lab, 2001, 47:29-33. 被引量：1
6Sayama H, Nakamura Y, Saito N, et al. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis. 1999. 10:537-540. 被引量：1
7Maeda K, Tsutamoto T, Wada A, et al. Plasma Brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure with symptomatic left ventricular dysfunction. Am. Heart J,1998, 135:825-832. 被引量：1
8Hall C, Kjekshus J, Eneroch P, et al. The plasma concentration of N-terminal proatrial natriuretie factor ANF (1-98) is related to prognosis in severe heart failure. Clin Cardiol, 1994, 17:191-195. 被引量：1
